This topic contains a solution. Click here to go to the answer

Author Question: The nurse discusses fetal development and states that the hormone responsible for suppressing the ... (Read 112 times)

DyllonKazuo

  • Hero Member
  • *****
  • Posts: 565
The nurse discusses fetal development and states that the hormone responsible for suppressing the maternal immunologic response to the fetus thereby facilitating physiological acceptance of the pregnancy is:
 
  A) Progesterone
  B) Estrogen
  C) Human placental lactogen
  D) Human chorionic gonadotropin

Question 2

The clinic nurse's best responses to a teenage mother's question regarding the presence of an intact hymen is:
  Select all answers that apply
 
  A) Your daughter's hymen will widen and perforate only with intercourse.
  B) The hymen is a small portion of tissue that forms a border around the vaginal opening in young girls
  C) The hymen can widen or perforate with tampon insertion, vulvar injury or with intercourse
  D) Bright red bleeding is always present following hymenal tearing



Related Topics

Need homework help now?

Ask unlimited questions for free

Ask a Question
Marked as best answer by a Subject Expert

aburgess

  • Sr. Member
  • ****
  • Posts: 361
Answer to Question 1

A

Answer to Question 2

B, C





 

Did you know?

The oldest recorded age was 122. Madame Jeanne Calment was born in France in 1875 and died in 1997. She was a vegetarian and loved olive oil, port wine, and chocolate.

Did you know?

Street names for barbiturates include reds, red devils, yellow jackets, blue heavens, Christmas trees, and rainbows. They are commonly referred to as downers.

Did you know?

Today, nearly 8 out of 10 pregnant women living with HIV (about 1.1 million), receive antiretrovirals.

Did you know?

Since 1988, the CDC has reported a 99% reduction in bacterial meningitis caused by Haemophilus influenzae, due to the introduction of the vaccine against it.

Did you know?

Bisphosphonates were first developed in the nineteenth century. They were first investigated for use in disorders of bone metabolism in the 1960s. They are now used clinically for the treatment of osteoporosis, Paget's disease, bone metastasis, multiple myeloma, and other conditions that feature bone fragility.

For a complete list of videos, visit our video library